Financial Enhancement Group’s CapForce IBD 50 ETF FFTY Stock Holding History

Financial Enhancement Group’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,462	Closed	-$280K	–	179
2022 Q3	$280K	Buy	11,462 +1,793	+19%	+$49.6K	0.06%	93
2022 Q2	$260K	Buy	9,669 +5,268	+120%	+$169K	0.06%	93
2022 Q1	$172K	Buy	4,401 +882	+25%	+$34.2K	0.03%	108
2021 Q4	$161K	Buy	3,519 +939	+36%	+$44.8K	0.03%	107
2021 Q3	$122K	Buy	2,580 +1,265	+96%	+$59.1K	0.02%	113
2021 Q2	$61K	Buy	+1,315	New	+$59.5K	0.01%	117
2018 Q3	–	Sell	-24,640	Closed	-$865K	–	258
2018 Q2	$865K	Buy	+24,640	New	+$859K	0.3%	46

Other funds holding FFTY

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

LJI Wealth Management Indianapolis, Indiana $712M AUM 13.75% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Financial Enhancement Group's FFTY Position: Q4 2022 in Review

Financial Enhancement Group sold out of CapForce IBD 50 ETF (FFTY) in Q4 2022, closing a stake of 11,462 shares — an estimated $280K sold.

Financial Enhancement Group first reported a position in FFTY in Q2 2018 and held it in 7 quarters. The position peaked at $865K in Q2 2018. 49 funds tracked by Wall St. Rank hold FFTY as of Q4 2022.

Financial Enhancement Group reported no remaining CapForce IBD 50 ETF position as of Q4 2022 after selling out during the quarter.
Financial Enhancement Group sold 11,462 CapForce IBD 50 ETF shares in Q4 2022, an estimated $280K.
Financial Enhancement Group first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 7 quarters.
Financial Enhancement Group's CapForce IBD 50 ETF position peaked at $865K in Q2 2018.
49 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.